Advances in Research Conference 2025: Generative Artificial Intelligence in Kidney Disease Research and Management

Online Product

The development of advanced artificial intelligence (AI), particularly large language models and generative AI, has started to impact basic science, clinical research, clinical practice, and everyday life. In the last three years, several applications of generative AI to drug discovery and clinical trial design have emerged and together have the potential to accelerate drug development timelines and impart major impacts on human health. Researchers in both fundamental and clinical research areas must be aware of these advances to incorporate them in their own academic work and to critically evaluate molecules and clinical trials driven by generative AI. Please note: no CE credit is available for this On-Demand product. ASN thanks the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Dr. Eric Brunskill, and Dr. Debbie Gipson for their assistance with this program. Congratulations to NIDDK on its 75th anniversary.